Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Clinical chemistry
View this publicationClinical chemistry
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publicationClinical epigenetics
View this publicationJAMA oncology
View this publicationAntimicrobial resistance and infection control
View this publicationAutoimmunity reviews
View this publicationFrontiers in medicine
View this publicationUltrasound in medicine & biology
View this publicationFrontiers in oncology
View this publicationInternational journal of cancer
View this publication